Randamized control study of EUS versus MRCP for choledocholithiasis that can not be diagnosed by CT.

Randamized control study of EUS versus MRCP for choledocholithiasis that can not be diagnosed by CT. - Randamized control study of EUS versus MRCP for choledocholithiasis that can not be diagnosed by CT.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036357

Enrollment

Registered

2019-04-01

Start date

2019-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

choledocholithiasis

Interventions

Patients with clinical suspicion of choledocholithiasis but a negative CT will be randomly allocated to EUS group. Patients with clinical suspicion of choledocholithiasis but a negative CT will be ra

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients who can not be diagnosed choledocholithiasis by CT. 2.Patients who meet the suspected diagnosis or diagnostic criteria according to Tokyo Guidelines 2018(TG18). 3.Patients with "mild" or "moderate" acute cholangitis,which is defined by TG18. 4.Patients with written informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients who have metal allergy. 2.Patients who have iron hypersensitivity. 3.Altered upper GI anatomy. 4.Patients who have gastrointestinal hemorrhage. 5.Pregnant,unwilling to practice contraception during the study, or lactating female. 6.Patients with "severe" acute cholangitis,which is defined by TG18. 7.Patients considered ineligible for this study.

Design outcomes

Primary

Measure	Time frame
Diagnostic accracy	—

Countries

Japan

Contacts

Public ContactMasato Suzuki

Yokohama Rosai Hospital Department of Gastroenterology

d07sm056@gmail.com045-474-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026